The Main Bottleneck for Non-Metastatic Pancreatic Adenocarcinoma in Past Decades: A Population-Based Analysis

BACKGROUND: Despite recent advancements in surgical techniques, chemotherapy, and radiotherapy, the 5-year survival rate of patients with pancreatic ductal adenocarcinoma (PDAC) remains an unsatisfactory ~8%. MATERIAL/METHODS: Data were extracted to identify patients with non-metastatic pancreatic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuqiang, Liu, Wenxue, Zhao, Lilan, Xu, Yang, Yan, Tingyu, Yang, Qionghui, Pei, Qian, Güngör, Cenap
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Database Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212811/
https://www.ncbi.nlm.nih.gov/pubmed/32358953
http://dx.doi.org/10.12659/MSM.921515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212811/
https://www.ncbi.nlm.nih.gov/pubmed/32358953
http://dx.doi.org/10.12659/MSM.921515

Ejemplares similares